Literature DB >> 6368105

Antimicrobial susceptibility testing (AST): a review of changing trends, quality control guidelines, test accuracy, and recommendation for the testing of beta-lactam drugs.

R N Jones.   

Abstract

The review that follows presents the changing trends in antimicrobial susceptibility testing observed from the author's clinical laboratory experience and the proficiency testing surveys of the College of American Pathologists (CAP). The CAP Microbiology Surveys show a clear trend toward standardized test methods of the National Committee for Clinical Laboratory Standard (NCCLS) and greater compliance with specified methods' technical steps. This has favorably influenced the laboratory performance on proficiency challenges where a 3-5% improvement has been noted over the last 5 years for the disk tests (overall acceptable rate of 95.2% in 1981). A concurrent increase in dilution test use, mainly broth microdilution methods, has resulted in greater than 25% of larger hospital laboratories reporting results as MICs (overall acceptable or good performance = 98%). Automated systems use also continues to increase, with user performance being monitored at an acceptable level. Quality control frequency may be reduced to once weekly without compromising test accuracy or patient care, but only after adequate daily or concurrent QC performance has been documented. Most methods continue to have problems in testing enterococci, methicillin-resistant staphylococci, and the class-disk concept appears to be less applicable. Recommendations are made for the testing of the newer semisynthetic penicillins and cephalosporins based on their spectrum comparability and cross-resistance studies with bacteria possessing known susceptibility or resistance mechanisms. The concept of "spectrum-class" is introduced with peer drugs within classes. The general trends and quality of antimicrobial susceptibility tests seem outstanding and point toward continued excellent intra- and interlaboratory reproducibility at the national level, primarily due to the efforts of the inspection and accreditation agencies, CAP, CDC, and other concerned professional groups.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6368105     DOI: 10.1016/0732-8893(83)90028-7

Source DB:  PubMed          Journal:  Diagn Microbiol Infect Dis        ISSN: 0732-8893            Impact factor:   2.803


  9 in total

1.  Multicenter Evaluation of Ceftazidime-Avibactam Susceptibility Testing of Enterobacterales and Pseudomonas aeruginosa on the Vitek 2 System.

Authors:  Romney Humphries; Shelley Campeau; Thomas E Davis; Kristin J Nagaro; Vincent J LaBombardi; Simone Franklin; Lisa Heimbach; Hari P Dwivedi
Journal:  J Clin Microbiol       Date:  2021-02-18       Impact factor: 5.948

2.  Comparison of BIOGRAM and commercial microdilution antimicrobial susceptibility test systems.

Authors:  R L Sautter; G A Denys
Journal:  J Clin Microbiol       Date:  1987-02       Impact factor: 5.948

3.  Accuracy and reproducibility of the AutoMicrobic System Gram-Negative General Susceptibility-Plus Card for testing selected challenge organisms.

Authors:  H L Nadler; C Dolan; L Mele; S R Kurtz
Journal:  J Clin Microbiol       Date:  1985-09       Impact factor: 5.948

4.  Comparison of a beta-lactamase induction test with a test that detects low-frequency resistance to cefotaxime.

Authors:  R E Menzies; D MacCulloch
Journal:  Antimicrob Agents Chemother       Date:  1985-04       Impact factor: 5.191

5.  How the microbiology laboratory can improve antimicrobial therapy.

Authors:  J A Washington
Journal:  Bull N Y Acad Med       Date:  1984-05

6.  Evaluation of the BIOGRAM antimicrobial susceptibility test system.

Authors:  R F D'Amato; L Hochstein; J R Vernaleo; D J Cleri; A A Wallman; M S Gradus; C Thornsberry
Journal:  J Clin Microbiol       Date:  1985-11       Impact factor: 5.948

7.  Comparison of two automated instrument systems for rapid susceptibility testing of gram-negative bacilli.

Authors:  J E Johnson; J H Jorgensen; S A Crawford; J S Redding; R C Pruneda
Journal:  J Clin Microbiol       Date:  1983-12       Impact factor: 5.948

8.  Effect of the source of Mueller-Hinton agar and resistance frequency on the detection of methicillin-resistant Staphylococcus aureus.

Authors:  J A Hindler; C B Inderlied
Journal:  J Clin Microbiol       Date:  1985-02       Impact factor: 5.948

Review 9.  Tests for bactericidal effects of antimicrobial agents: technical performance and clinical relevance.

Authors:  L R Peterson; C J Shanholtzer
Journal:  Clin Microbiol Rev       Date:  1992-10       Impact factor: 26.132

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.